Learn More
Medchemexpress LLC SRX3177 | 2241237-51-2 | C31H32N6O4S | 1 ML

Supplier: Medchemexpress LLC HY15389410MM/1ML
SRX3177 is a triple inhibitor of CDK4/6, PI3K, and BRD4. This compound blocks the interaction between the SARS-CoV-2 E protein and the BRD2/4 BD1 domain, which helps restore E protein-attenuated NF-κB activity. SRX3177 shows broad cytotoxic activity against cancer cells and can be used for the study of anti-SARS-CoV-2 and cancer.
- Inhibits CDK4/6, PI3K, and BRD4
- Blocks interaction between SARS-CoV-2 E protein and BRD2/4 BD1 domain
- Restores E protein-attenuated NF-κB activity
- Exhibits broad cytotoxic activity against cancer cells
- Useful for anti-SARS-CoV-2 research
- Useful for cancer research
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.